03:34 AM EST, 02/25/2025 (MT Newswires) -- Daniel Lynch, Director, on February 20, 2025, sold 47,600 shares in SpringWorks Therapeutics ( SWTX ) for $2,866,534. Following the Form 4 filing with the SEC, Lynch has control over a total of 82,944 common shares of the company, with 82,944 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1773427/000110465925016614/xslF345X05/tm257488-1_4seq1.xml